Norditropin Improves Muscle Function in Phase III RCT of U.S. Males with ALS
Reading Time: 2 minutesIntroduction Amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder, disproportionately impacts American males, with incidence rates approximately 20% higher in men than women according to CDC surveillance data from 2015-2020. Characterized by motor neuron degeneration, ALS leads to profound skeletal muscle atrophy, weakness, and functional decline, severely compromising quality of life. Norditropin (somatropin), a recombinant human growth hormone (rhGH), has... Read more »
